{"DataElement":{"publicId":"3771213","version":"1","preferredName":"Person HLA Typing Assessment Type","preferredDefinition":"the type of human leukocyte antigen (HLA) profiles analyzed or identified in a person.","longName":"PsnHLAAssTp","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3771212","version":"1","preferredName":"Person HLA Typing Assessment","preferredDefinition":"information related to a person and a class of blood or tissue samples analyzed to determine their human leukocyte antigen (HLA) profiles.","longName":"PsnHLATpAss","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3766491","version":"1","preferredName":"HLA Typing Assessment","preferredDefinition":"A process in which blood or tissue samples are analyzed to determine their human leukocyte antigen (HLA) profiles.:The final result of a determination of the value, significance, or extent of.","longName":"C71329:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HLA Typing","conceptCode":"C71329","definition":"A process in which blood or tissue samples are analyzed to determine their human leukocyte antigen (HLA) profiles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCEEA7BE-D02C-8190-E040-BB89AD43044A","latestVersionIndicator":"Yes","beginDate":"2013-05-17","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-17","modifiedBy":"ONEDATA","dateModified":"2013-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD6647E8-A175-891F-E040-BB89AD434DBE","latestVersionIndicator":"Yes","beginDate":"2013-05-23","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3759967","version":"1","preferredName":"HLA Typing Type","preferredDefinition":"an identifiable class of blood or tissue samples analyzed to determine human leukocyte antigen (HLA) profiles.","longName":"HLAType","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"HLA C","valueDescription":"HLA C","ValueMeaning":{"publicId":"3759968","version":"1","preferredName":"HLA C","longName":"3759968","preferredDefinition":"This gene plays a role in both immune responses and  histocompatibility processes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HLA-C Gene","conceptCode":"C62758","definition":"This gene plays a role in both immune responses and histocompatibility processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCA34D1F-E260-3A8A-E040-BB89AD43014E","latestVersionIndicator":"Yes","beginDate":"2013-05-13","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCA34D1F-E278-3A8A-E040-BB89AD43014E","beginDate":"2013-05-13","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-13","modifiedBy":"ONEDATA","dateModified":"2013-05-13","deletedIndicator":"No"},{"value":"HLA B","valueDescription":"HLA B","ValueMeaning":{"publicId":"3263257","version":"1","preferredName":"HLA B","longName":"3263257","preferredDefinition":"This gene plays a role in both immune responses and histocompatibility processes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HLA-B Gene","conceptCode":"C62778","definition":"This gene plays a role in both immune responses and histocompatibility processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAC86B3F-41A3-9EE3-E040-BB89AD435873","latestVersionIndicator":"Yes","beginDate":"2011-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-18","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCA34D1F-E28D-3A8A-E040-BB89AD43014E","beginDate":"2013-05-13","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-13","modifiedBy":"ONEDATA","dateModified":"2013-05-13","deletedIndicator":"No"},{"value":"HLA A","valueDescription":"HLA A","ValueMeaning":{"publicId":"3263258","version":"1","preferredName":"HLA A","longName":"3263258","preferredDefinition":"This gene is involved in immune responses and histocompatibility processes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HLA-A Gene","conceptCode":"C28585","definition":"This gene is involved in immune responses and histocompatibility processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAC86B3F-41C6-9EE3-E040-BB89AD435873","latestVersionIndicator":"Yes","beginDate":"2011-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-18","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCA34D1F-E2A2-3A8A-E040-BB89AD43014E","beginDate":"2013-05-13","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-13","modifiedBy":"ONEDATA","dateModified":"2013-05-13","deletedIndicator":"No"},{"value":"HLA DRB1","valueDescription":"HLA DRB1","ValueMeaning":{"publicId":"3282649","version":"1","preferredName":"HLA DRB1","longName":"3282649","preferredDefinition":"The class of genes that encode proteins of the major histocompatibility complex, class II, DR beta; HLA type II genes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HLA-DRB1 Gene","conceptCode":"C19409","definition":"This gene is involved in immunoregulation and antigen presentation. The gene has several hundred alleles and polymorphism typing is routinely performed for bone marrow and kidney transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD659607-E80E-D2D3-E040-BB89AD435CA4","latestVersionIndicator":"Yes","beginDate":"2011-09-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-20","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCA34D1F-E2B7-3A8A-E040-BB89AD43014E","beginDate":"2013-05-13","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-13","modifiedBy":"ONEDATA","dateModified":"2013-05-13","deletedIndicator":"No"},{"value":"HLA DQB1","valueDescription":"HLA DQB1","ValueMeaning":{"publicId":"3334837","version":"1","preferredName":"HLA DQB1","longName":"3334837","preferredDefinition":"This gene is involved in the mediation of antigen presentation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HLA-DQB1 Gene","conceptCode":"C70614","definition":"This gene is involved in the mediation of antigen presentation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B428B782-CB93-E155-E040-BB89AD43470F","latestVersionIndicator":"Yes","beginDate":"2011-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-12-15","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCA34D1F-E2CC-3A8A-E040-BB89AD43014E","beginDate":"2013-05-13","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-13","modifiedBy":"ONEDATA","dateModified":"2013-05-13","deletedIndicator":"No"},{"value":"HLA-DP","valueDescription":"HLA-DP Antigen","ValueMeaning":{"publicId":"2829705","version":"1","preferredName":"HLA-DP Antigen","longName":"2829705","preferredDefinition":"HLA-DP antigen is a class of glycoproteins that consist of dimers of alpha and beta subunits, which are encoded by the polymorphic human genes HLA-DPA1 and HLA-DPB1, respectively. This protein complex is expressed primarily in lymphoid cells and function to present antigens for CD4+ T lymphocytes. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HLA-DP Antigen","conceptCode":"C71274","definition":"HLA-DP antigen is a class of glycoproteins that consist of dimers of alpha and beta subunits, which are encoded by the polymorphic human genes HLA-DPA1 and HLA-DPB1, respectively. This protein complex is expressed primarily in lymphoid cells and function to present antigens for CD4+ T lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61694C36-36AD-DC55-E040-BB89AD43020E","latestVersionIndicator":"Yes","beginDate":"2009-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-26","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3291B7E-D40E-AB08-E040-BB89AD437FF9","beginDate":"2014-02-24","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-24","modifiedBy":"ONEDATA","dateModified":"2014-02-24","deletedIndicator":"No"},{"value":"HLA-DQ","valueDescription":"HLA-DQ Antigen","ValueMeaning":{"publicId":"2829706","version":"1","preferredName":"HLA-DQ Antigen","longName":"2829706","preferredDefinition":"HLA-DQ antigen is a class of glycoproteins that consist of dimers of alpha and beta subunits, which are encoded by the polymorphic human genes HLA-DQA1 and HLA-DQB1, respectively. This protein complex is expressed primarily in lymphoid cells and function to present antigens for CD4+ T lymphocytes. Certain HLA-DQ protein variants are associated with susceptibility to insulin-dependent diabetes mellitus and several autoimmune diseases. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HLA-DQ Antigen","conceptCode":"C62792","definition":"HLA-DQ antigen is a class of glycoproteins that consist of dimers of alpha and beta subunits, which are encoded by the polymorphic human genes HLA-DQA1 and HLA-DQB1, respectively. This protein complex is expressed primarily in lymphoid cells and function to present antigens for CD4+ T lymphocytes. Certain HLA-DQ protein variants are associated with susceptibility to insulin-dependent diabetes mellitus and several autoimmune diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61694C36-36D2-DC55-E040-BB89AD43020E","latestVersionIndicator":"Yes","beginDate":"2009-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3291B7E-D418-AB08-E040-BB89AD437FF9","beginDate":"2014-02-24","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-24","modifiedBy":"ONEDATA","dateModified":"2014-02-24","deletedIndicator":"No"},{"value":"HLA-DR","valueDescription":"HLA-DR Antigen","ValueMeaning":{"publicId":"2829707","version":"1","preferredName":"HLA-DR Antigen","longName":"2829707","preferredDefinition":"Encoded by multiple HLA-DRA and HLA-DRB genes in a complex variable 5 cM region of MHC between HLA-B and -D, HLA-DR Antigens are Class II histocompatibility transmembrane glycoprotein heterodimers of alpha (heavy, 35-kD) and beta (light, 27-kD) chains. Located predominantly on B cells and macrophages, HLA-DR antigens function in antigen presentation to regulatory T cells in the immune response and in self/nonself discrimination. Invariant alpha and polymorphic beta chains have glycosylated N-termini, hydrophobic membrane regions, and hydrophilic C-termini. The heterodimer consists of 4 extracellular domains; invariant alpha-1, polymorphic N-terminal beta-1, and conserved Ig-like alpha-2 and beta-2. Alpha-1 and alpha-2 contain disulfide loops. Beta-1 contains 2 small variable regions. Alpha sequences have relatively simple structure; beta chains carry the major polymorphic determinants. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HLA-DR Antigen","conceptCode":"C16692","definition":"Encoded by multiple HLA-DRA and HLA-DRB genes in a complex variable 5 cM region of MHC between HLA-B and -D, HLA-DR Antigens are Class II histocompatibility transmembrane glycoprotein heterodimers of alpha (heavy, 35-kD) and beta (light, 27-kD) chains. Located predominantly on B cells and macrophages, HLA-DR antigens function in antigen presentation to regulatory T cells in the immune response and in self/nonself discrimination. Invariant alpha and polymorphic beta chains have glycosylated N-termini, hydrophobic membrane regions, and hydrophilic C-termini. The heterodimer consists of 4 extracellular domains; invariant alpha-1, polymorphic N-terminal beta-1, and conserved Ig-like alpha-2 and beta-2. Alpha-1 and alpha-2 contain disulfide loops. Beta-1 contains 2 small variable regions. Alpha sequences have relatively simple structure; beta chains carry the major polymorphic determinants.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61694C36-36F7-DC55-E040-BB89AD43020E","latestVersionIndicator":"Yes","beginDate":"2009-01-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-26","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3291B7E-D422-AB08-E040-BB89AD437FF9","beginDate":"2014-02-24","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-24","modifiedBy":"ONEDATA","dateModified":"2014-02-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2186371","version":"1","preferredName":"Type","preferredDefinition":"a subdivision of a particular kind of thing.","longName":"C0332307","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C0332307","definition":"Type; a subdivision of a particular kind of thing.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A894-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCA34D1F-E24C-3A8A-E040-BB89AD43014E","latestVersionIndicator":"Yes","beginDate":"2013-05-13","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-13","modifiedBy":"WONGW","dateModified":"2014-02-24","changeDescription":"Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"}],"ReferenceDocuments":[{"name":"HLA Type:","type":"Preferred Question Text","description":"HLA Type:","url":null,"context":"COG"},{"name":"ECOG CRF 1","type":"Alternate Question Text","description":"Transplant Compatibility","url":null,"context":"ECOG-ACRIN"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Which HLA antigens were typed?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD6647E8-A18D-891F-E040-BB89AD434DBE","latestVersionIndicator":"Yes","beginDate":"2013-05-23","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-23","modifiedBy":"MAESKEB","dateModified":"2022-04-26","changeDescription":". Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}